vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Vitesse Energy, Inc. (VTS). Click either name above to swap in a different company.
Vitesse Energy, Inc. is the larger business by last-quarter revenue ($58.6M vs $47.7M, roughly 1.2× IRONWOOD PHARMACEUTICALS INC). Vitesse Energy, Inc. runs the higher net margin — -1.3% vs -4.8%, a 3.5% gap on every dollar of revenue. On growth, Vitesse Energy, Inc. posted the faster year-over-year revenue change (4.8% vs -47.3%). Over the past eight quarters, Vitesse Energy, Inc.'s revenue compounded faster (-2.1% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Vitesse Energy, Inc. is a U.S.-headquartered independent energy company focused on exploration, development, and production of oil and natural gas assets. It operates primarily in high-potential onshore basins including North Dakota's Williston Basin, serving domestic and global upstream energy market demand.
IRWD vs VTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $58.6M |
| Net Profit | $-2.3M | $-739.0K |
| Gross Margin | — | — |
| Operating Margin | 14.3% | -12.0% |
| Net Margin | -4.8% | -1.3% |
| Revenue YoY | -47.3% | 4.8% |
| Net Profit YoY | -200.9% | 85.6% |
| EPS (diluted) | $0.01 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $58.6M | ||
| Q3 25 | $122.1M | $67.4M | ||
| Q2 25 | $85.2M | $81.8M | ||
| Q1 25 | $41.1M | $66.2M | ||
| Q4 24 | $90.5M | $55.9M | ||
| Q3 24 | $91.6M | $58.3M | ||
| Q2 24 | $94.4M | $66.6M | ||
| Q1 24 | $74.9M | $61.2M |
| Q4 25 | $-2.3M | $-739.0K | ||
| Q3 25 | $40.1M | $-1.3M | ||
| Q2 25 | $23.6M | $24.7M | ||
| Q1 25 | $-37.4M | $2.7M | ||
| Q4 24 | $2.3M | $-5.1M | ||
| Q3 24 | $3.6M | $17.4M | ||
| Q2 24 | $-860.0K | $10.9M | ||
| Q1 24 | $-4.2M | $-2.2M |
| Q4 25 | 14.3% | -12.0% | ||
| Q3 25 | 61.8% | 0.2% | ||
| Q2 25 | 53.2% | 22.8% | ||
| Q1 25 | -70.7% | 8.1% | ||
| Q4 24 | 34.8% | 3.7% | ||
| Q3 24 | 28.0% | 15.4% | ||
| Q2 24 | 26.5% | 25.2% | ||
| Q1 24 | 14.7% | 21.4% |
| Q4 25 | -4.8% | -1.3% | ||
| Q3 25 | 32.8% | -1.9% | ||
| Q2 25 | 27.7% | 30.2% | ||
| Q1 25 | -90.9% | 4.0% | ||
| Q4 24 | 2.5% | -9.2% | ||
| Q3 24 | 4.0% | 29.9% | ||
| Q2 24 | -0.9% | 16.4% | ||
| Q1 24 | -5.6% | -3.6% |
| Q4 25 | $0.01 | $-0.01 | ||
| Q3 25 | $0.23 | $-0.03 | ||
| Q2 25 | $0.14 | $0.60 | ||
| Q1 25 | $-0.23 | $0.08 | ||
| Q4 24 | $0.03 | $-0.15 | ||
| Q3 24 | $0.02 | $0.53 | ||
| Q2 24 | $-0.01 | $0.33 | ||
| Q1 24 | $-0.03 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $629.3M |
| Total Assets | $396.9M | $893.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | $4.5M | ||
| Q4 24 | $88.6M | $3.0M | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $629.3M | ||
| Q3 25 | $-264.2M | $650.3M | ||
| Q2 25 | $-308.2M | $671.9M | ||
| Q1 25 | $-334.1M | $667.7M | ||
| Q4 24 | $-301.3M | $500.3M | ||
| Q3 24 | $-311.3M | $520.4M | ||
| Q2 24 | $-321.7M | $518.5M | ||
| Q1 24 | $-330.5M | $522.7M |
| Q4 25 | $396.9M | $893.4M | ||
| Q3 25 | $396.1M | $932.9M | ||
| Q2 25 | $342.9M | $951.5M | ||
| Q1 25 | $327.2M | $975.2M | ||
| Q4 24 | $350.9M | $810.9M | ||
| Q3 24 | $389.5M | $791.2M | ||
| Q2 24 | $395.6M | $778.4M | ||
| Q1 24 | $438.8M | $749.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $37.4M |
| Free Cash FlowOCF − Capex | $74.6M | — |
| FCF MarginFCF / Revenue | 156.3% | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $37.4M | ||
| Q3 25 | $47.6M | $49.4M | ||
| Q2 25 | $-15.1M | $66.0M | ||
| Q1 25 | $20.0M | $17.5M | ||
| Q4 24 | $15.2M | $34.7M | ||
| Q3 24 | $9.9M | $45.7M | ||
| Q2 24 | $33.5M | $35.2M | ||
| Q1 24 | $45.0M | $39.4M |
| Q4 25 | $74.6M | — | ||
| Q3 25 | $47.6M | — | ||
| Q2 25 | $-15.1M | — | ||
| Q1 25 | $19.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $33.4M | — | ||
| Q1 24 | $44.9M | — |
| Q4 25 | 156.3% | — | ||
| Q3 25 | 39.0% | — | ||
| Q2 25 | -17.7% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.8% | — | ||
| Q2 24 | 35.4% | — | ||
| Q1 24 | 60.0% | — |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | 1.19× | — | ||
| Q2 25 | -0.64× | 2.68× | ||
| Q1 25 | — | 6.56× | ||
| Q4 24 | 6.74× | — | ||
| Q3 24 | 2.71× | 2.62× | ||
| Q2 24 | — | 3.22× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
VTS
| Oil Reserves | $54.5M | 93% |
| Natural Gas Reserves | $4.2M | 7% |
